Cholesterol promotes the interaction of Alzheimer β-amyloid monomer with lipid bilayer.

Cholesterol in the plasma membrane plays an important role in the pathogenesis of Alzheimer's disease, but the exact function of cholesterol in the regulation of amyloid-β (Aβ) generation, aggregation, and toxicity remains elusive. To gain insight into the bioactivity of cholesterol, we investigate the effect of cholesterol levels on the interaction of Aβ(1-42) monomer with the zwitterionic 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) bilayer containing different mole fractions of cholesterol from χ=0, 0.2, to 0.4 using all-atom molecular dynamics simulations. Simulation results show that an increased cholesterol level alters the structure, dynamics, and surface chemistry of the lipid bilayer, leading to increased bilayer thickness, hydrophobic chain order, surface hydrophobicity, and decreased lipid mobility. All these effects significantly promote the binding of Aβ to the lipid bilayer. Mechanistically, the adsorption of Aβ on the bilayer is a cooperative process. First, charged residues act as anchors to establish the initial binding of Aβ to phosphate headgroups of the bilayer driven by electrostatic interactions, which further facilitates hydrophobic residues to reside on the bilayer. Once hydrophobic residues especially from C-terminus are locked on the bilayer, the interactions among charged residues, lipid bilayer, and calcium ions are optimized to provide additional attractive forces to stabilize Aβ adsorbed on or inserted into the lipid bilayer. Inclusion of cholesterol makes this binding process more energetically favorable. Upon adsorption on the bilayer, Aβ appears to preferentially adopt α-helical or unstructured conformation. This work supports that cholesterol acts as a promoter for Aβ--membrane interactions, which would facilitate Aβ aggregation and membrane insertion.

[1]  Sara M. Butterfield,et al.  Amyloidogenic Protein—Membrane Interactions: Mechanistic Insight from Model Systems , 2010 .

[2]  J. Ruysschaert,et al.  β-Sheet Structured β-Amyloid(1-40) Perturbs Phosphatidylcholine Model Membranes , 2007 .

[3]  Alexander D. MacKerell,et al.  Extending the treatment of backbone energetics in protein force fields: Limitations of gas‐phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations , 2004, J. Comput. Chem..

[4]  J McLaurin,et al.  Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity. , 2001, Journal of molecular biology.

[5]  M. Berkowitz,et al.  Structure of the amyloid-beta (1-42) monomer absorbed to model phospholipid bilayers: a molecular dynamics study. , 2009, The journal of physical chemistry. B.

[6]  Ka Yee C. Lee,et al.  Insertion of Alzheimer’s Aβ40 Peptide into Lipid Monolayers , 2004 .

[7]  M. Lösche,et al.  Soluble amyloid beta-oligomers affect dielectric membrane properties by bilayer insertion and domain formation: implications for cell toxicity. , 2008, Biophysical journal.

[8]  Jo V. Rushworth,et al.  Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes , 2010, International journal of Alzheimer's disease.

[9]  A. Bonvin,et al.  The α‐to‐β Conformational Transition of Alzheimer's Aβ‐(1–42) Peptide in Aqueous Media is Reversible: A Step by Step Conformational Analysis Suggests the Location of β Conformation Seeding , 2006 .

[10]  J. McLaurin,et al.  Membrane Disruption by Alzheimer β-Amyloid Peptides Mediated through Specific Binding to Either Phospholipids or Gangliosides , 1996, The Journal of Biological Chemistry.

[11]  Taehoon Kim,et al.  CHARMM‐GUI: A web‐based graphical user interface for CHARMM , 2008, J. Comput. Chem..

[12]  D. Tieleman,et al.  Molecular dynamics study of the effect of cholesterol on the properties of lipid monolayers at low surface tensions. , 2009, Physical chemistry chemical physics : PCCP.

[13]  Ka Yee C. Lee,et al.  Insertion of Alzheimer's A beta 40 peptide into lipid monolayers. , 2004, Biophysical journal.

[14]  R. Tycko,et al.  Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. , 2006, Biochemistry.

[15]  R. Nussinov,et al.  New structures help the modeling of toxic amyloidbeta ion channels. , 2008, Trends in biochemical sciences.

[16]  J. McLaurin,et al.  Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes. , 1997, European journal of biochemistry.

[17]  P. Coppock,et al.  Atomistic simulation of cholesterol effects on miscibility of saturated and unsaturated phospholipids: implications for liquid-ordered/liquid-disordered phase coexistence. , 2011, Journal of the American Chemical Society.

[18]  A. D'Ursi,et al.  Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain. , 2002, European journal of biochemistry.

[19]  Felipe Garcia Quiroz,et al.  Amyloid-β-Induced Ion Flux in Artificial Lipid Bilayers and Neuronal Cells: Resolving a Controversy , 2009, Neurotoxicity Research.

[20]  J. Seelig,et al.  Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes. , 1997, Biochemistry.

[21]  I. W. Levin,et al.  Packing characteristics of highly unsaturated bilayer lipids: Raman spectroscopic studies of multilamellar phosphatidylcholine dispersions. , 1991, Biochemistry.

[22]  John Woulfe,et al.  Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production , 2008, Neurobiology of Disease.

[23]  N. Arispe,et al.  Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP (1–40) and (1–42) peptides , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  D Thirumalai,et al.  Transmembrane structures of amyloid precursor protein dimer predicted by replica-exchange molecular dynamics simulations. , 2009, Journal of the American Chemical Society.

[25]  M. Brameshuber,et al.  Cholesterol Slows down the Lateral Mobility of an Oxidized Phospholipid in a Supported Lipid Bilayer , 2010, Langmuir : the ACS journal of surfaces and colloids.

[26]  A. Bonvin,et al.  The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding. , 2006, Chembiochem : a European journal of chemical biology.

[27]  E. Jakobsson,et al.  Combined Monte Carlo and molecular dynamics simulation of hydrated dipalmitoyl–phosphatidylcholine–cholesterol lipid bilayers , 2001 .

[28]  A. Smondyrev,et al.  Structure of dipalmitoylphosphatidylcholine/cholesterol bilayer at low and high cholesterol concentrations: molecular dynamics simulation. , 1999, Biophysical journal.

[29]  Justin A. Lemkul,et al.  Perturbation of membranes by the amyloid β‐peptide – a molecular dynamics study , 2009, The FEBS journal.

[30]  J. Schulz,et al.  Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neurons , 2006, Neurobiology of Disease.

[31]  Hai Lin,et al.  Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm. , 2007, Biochimica et biophysica acta.

[32]  Jeremy C. Smith,et al.  Differential effects of cholesterol, ergosterol and lanosterol on a dipalmitoyl phosphatidylcholine membrane: a molecular dynamics simulation study. , 2007, The journal of physical chemistry. B.

[33]  J. Danielsson,et al.  Positioning of the Alzheimer Aβ(1–40) peptide in SDS micelles using NMR and paramagnetic probes , 2007, Journal of biomolecular NMR.

[34]  B. Smit,et al.  Molecular simulation of the effect of cholesterol on lipid-mediated protein-protein interactions. , 2010, Biophysical journal.

[35]  M. Berkowitz,et al.  Interaction between amyloid-beta (1-42) peptide and phospholipid bilayers: a molecular dynamics study. , 2009, Biophysical journal.

[36]  C. Yip,et al.  Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption. , 2001, Biophysical journal.

[37]  L. Lue,et al.  Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production. , 2008, Neurobiology of disease.

[38]  H. Shao,et al.  Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease. , 1999, Journal of molecular biology.

[39]  D. Wales,et al.  Transmembrane structures for Alzheimer's Aβ(1-42) oligomers. , 2010, Journal of the American Chemical Society.

[40]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[41]  James H. Davis,et al.  Phase equilibria of cholesterol/dipalmitoylphosphatidylcholine mixtures: 2H nuclear magnetic resonance and differential scanning calorimetry. , 1990, Biochemistry.

[42]  A. Gliozzi,et al.  A protective role for lipid raft cholesterol against amyloid-induced membrane damage in human neuroblastoma cells. , 2009, Biochimica et biophysica acta.

[43]  M. Stefani,et al.  Cholesterol in Alzheimer's disease: unresolved questions. , 2009, Current Alzheimer research.

[44]  W. Noble,et al.  Linking Amyloid and Tau Pathology in Alzheimer's Disease: The Role of Membrane Cholesterol in Aβ-Mediated Tau Toxicity , 2009, The Journal of Neuroscience.

[45]  Jie Zheng,et al.  Alzheimer Abeta(1-42) monomer adsorbed on the self-assembled monolayers. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[46]  S. Ji,et al.  Cholesterol Is an Important Factor Affecting the Membrane Insertion of β-Amyloid Peptide (Aβ1–40), Which May Potentially Inhibit the Fibril Formation* , 2002, The Journal of Biological Chemistry.

[47]  G. Vitiello,et al.  Interaction between Alzheimer's Abeta(25-35) peptide and phospholipid bilayers: the role of cholesterol. , 2008, Biochimica et biophysica acta.

[48]  A. Watts,et al.  Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. , 2004, Journal of molecular biology.

[49]  Ruth Nussinov,et al.  PatchDock and SymmDock: servers for rigid and symmetric docking , 2005, Nucleic Acids Res..

[50]  K. Gawrisch,et al.  Lateral diffusion rates of lipid, water, and a hydrophobic drug in a multilamellar liposome. , 2003, Biophysical journal.

[51]  J. Seelig,et al.  Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes. , 1995, Journal of molecular biology.

[52]  Laxmikant V. Kale,et al.  NAMD2: Greater Scalability for Parallel Molecular Dynamics , 1999 .

[53]  Ruth Nussinov,et al.  FireDock: Fast interaction refinement in molecular docking , 2007, Proteins.

[54]  Justin A. Lemkul,et al.  A comparative molecular dynamics analysis of the amyloid beta-peptide in a lipid bilayer. , 2008, Archives of biochemistry and biophysics.